Dr Reddys Labs has announced its third quarter results of FY10. It has reported consolidated net loss of Rs 233 crore in the quarter ended December 2009 as against profit of Rs 192.4 crore in the same period of last year.
Its adjusted net profit at Rs 225 crore. The company has written off goodwill of Rs 458 crore.
Net sales declined to Rs 1,730 crore from Rs 1,840 crore.
Its consolidated net loss stood at Rs 520 crore and revenues at Rs 1,730 crore, as per International Financial Reporting Standards.
EBIDTA (earning before interest, depreciation, tax and amortisation) improved to 21.4% versus 18.2%.
| Particulars | Dec-09 | Sep-09 | Jun-09 | Mar-09 |
| Net Sales / Interest Earned / Operating Income | 1050.74 | 1125.86 | 1197.82 | 1144.8 |
| Other Income | 35.64 | 13.15 | 22.89 | 21.71 |
| Expenditure | -805.9 | -886.77 | -876.33 | -866.47 |
| Interest | -2.75 | -0.1 | -3.55 | -6.5 |
| Profit Before Depreciation and Tax | 277.73 | 252.14 | 340.83 | 293.54 |
| Depreciation | -54.54 | -55.08 | -51.85 | -52.47 |
| Profit before Tax | 223.19 | 197.06 | 288.98 | 241.07 |
| Tax | -54.77 | - | -61.54 | -84.9 |
| Net Profit | 168.42 | 197.06 | 227.44 | 156.17 |
| Equity Capital | 84.41 | 84.37 | 84.33 | 84.23 |
Source: Moneycontrol.com
Courtesy moneycontrol.com
Courtesy moneycontrol.com
Also check
Posts
No comments:
Post a Comment